Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

12 HR Treprostinil 2.5 MG Extended Release Oral Tablet

Known as: treprostinil 2.5 MG 12HR Extended Release Oral Tablet, TREPROSTINIL DIOLAMINE 2.5MG SA TAB, TREPROSTINIL DIOLAMINE 2.5MG TAB,SA [VA Product] 
 
National Institutes of Health

Related topics

Related topics

7 relations
Decreased Blood Pressure [PE]Extended Release Oral TabletHypersensitivityProstaglandins I
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice
Pulmonary fibrosis is a progressive disease characterized by disruption of lung architecture and deregulation of the pulmonary… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2019
2019
INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH) (Investigation of the Safety and Pharmacology of Dry Powder…
Summary of Objectives Inhalational drug delivery to treat PAH is attractive due to enhanced pulmonary specificity and reduced… Expand
Is this relevant?
2017
2017
Inhalation of dry powder INS1009 (DP-INS1009) does not activate the cough reflex in guinea pigs: a comparison with nebulized treprostinil
 
Is this relevant?
2016
2016
Treprostinil Iontophoresis Improves Digital Blood Flow during Local Cooling in Systemic Sclerosis.
INTRODUCTION Severe Raynaud's syndrome and DUs are the most prevalent manifestations of SSc peripheral microvascular disease. We… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Review
2015
Review
2015
Treprostinil Iontophoresis in Idiopathic Pulmonary Arterial Hypertension.
Idiopathic pulmonary arterial hypertension (PAH) is a progressive disease without identifiable etiology and is characterized by… Expand
  • figure 1
  • table 1
Is this relevant?
2013
2013
Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion
IntroductionTreprostinil diethanolamine is an innovative salt form of the prostacyclin analogue, treprostinil sodium, developed… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
In vitro delivery of aerosolized treprostinil via modern mechanical ventilation.
BACKGROUND The Tyvaso Inhalation System is a hand-held nebulizer system used to administer treprostinil, an approved therapy for… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2011
2011
An Evaluation Of The Pharmacokinetics And Safety Of A Single Dose Of UT-15C SR (Treprostinil Diethanolamine) In Subjects With Hepatic Impairment Compared With Healthy Volunteers
 
Is this relevant?
2009
2009
Verfahren zur herstellung von treprostinil-monohydrat und seine verwendung zur lagerung und zum transport
 
Is this relevant?
Review
2008
Review
2008
Treprostinil NDA accepted for review by US FDA
  • 2008
    • Corpus ID: 195105008
 
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE